A recent study in CRC by Fiegle et al. showed that the combined blockade of CTLA-4 and PD-L1 increased the levels of the pro-inflammatory Th1/M1-related cytokines, increased NOS+ macrophages in the tumor tissue and reduced PD-L1+ macrophages (179). Here, CTLA4 is linked to colorectal carcinoma.